Serum DHCR24 Auto-antibody as a new Biomarker for Progression of Hepatitis C

BACKGROUND: New biomarkers are needed to identify the stage of hepatitis C virus (HCV)-infected diseases in order to reduce the mortality rates. Herein, we investigated whether serum 3β-hydroxysterol Δ24-reductase antibody (DHCR24 Ab) may serve as a prognostic marker for hepatitis C infection progre...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:EBioMedicine
Main Authors: Ezzikouri, Sayeh, Kimura, Kiminori, Sunagozaka, Hajime, Kaneko, Shuichi, Inoue, Kazuaki, Nishimura, Tomohiro, Hishima, Tsunekazu, Kohara, Michinori, Tsukiyama-Kohara, Kyoko
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2015
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4535309/
https://ncbi.nlm.nih.gov/pubmed/26288822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2015.04.007
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados